PUBLISHER: TechNavio | PRODUCT CODE: 2172529
PUBLISHER: TechNavio | PRODUCT CODE: 2172529
Global Microfluidics For Healthcare Application Market 2026-2030
The global microfluidics for healthcare application market is forecasted to grow by USD 164083.1 mn during 2025-2030, accelerating at a CAGR of 27.1% during the forecast period. The report on the global microfluidics for healthcare application market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by decentralized point of care diagnostics demand, expansion of precision medicine and genomics, adoption of organ on chip models.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 24.5% |
| CAGR | 27.1% |
| Incremental Value | $164083.1 mn |
Technavio's global microfluidics for healthcare application market is segmented as below:
By Application
- In-vitro diagnostics
- Pharmaceutical research
- Drug delivery services
By Material
- Polymer-based
- Glass-based
- Silicon-based
By Product Type
- Microfluidic-based devices
- Microfluidic components
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- South America
- Brazil
- Argentina
- Chile
- Middle East and Africa
- UAE
- South Africa
- Turkey
- Rest of World (ROW)
This study identifies the rise of continuous wearable microfluidic biosensors as one of the prime reasons driving the global microfluidics for healthcare application market growth during the next few years. Also, adoption of microfluidic lipid nanoparticle synthesis and implementation of microfluidic cell isolation workflows will lead to sizable demand in the market.
The report on the global microfluidics for healthcare application market covers the following areas:
- Global microfluidics for healthcare application market sizing
- Global microfluidics for healthcare application market forecast
- Global microfluidics for healthcare application market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global microfluidics for healthcare application market vendors that include 10X Genomics Inc., Agilent Technologies Inc., Axxin Pty Ltd, Becton Dickinson and Co., Bio Rad Laboratories Inc., Elvesys SAS, Emulate Inc., Fluigent SA, Illumina Inc., Microfluidic Chipshop GmbH, Micronit BV, MIMETAS BV, Parker Hannifin Corp., QIAGEN N.V., Revvity Inc., SMC Corp., Sphere Fluidics Ltd., Standard BioTools Inc., Thermo Fisher Scientific Inc., uFluidix Inc.. Also, the global microfluidics for healthcare application market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Material
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Microfluidics For Healthcare Application Market 2020 - 2024
- Historic Market Size - Data Table on Global Microfluidics For Healthcare Application Market 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 Material segment analysis 2020 - 2024
- Historic Market Size - Material Segment 2020 - 2024 ($ million)
- 5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Microfluidics for Healthcare Application Market
- 6.2 Impact of geopolitical conflicts on Global Microfluidics for Healthcare Application Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 In-vitro diagnostics - Market size and forecast 2025-2030
- 8.4 Pharmaceutical research - Market size and forecast 2025-2030
- 8.5 Drug delivery services - Market size and forecast 2025-2030
- 8.6 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by Material
- 9.1 Market segments
- 9.2 Comparison by Material
- 9.3 Polymer-based - Market size and forecast 2025-2030
- 9.4 Glass-based - Market size and forecast 2025-2030
- 9.5 Silicon-based - Market size and forecast 2025-2030
- 9.6 Market opportunity by Material
- Market opportunity by Material ($ million)
10 Market Segmentation by Product Type
- 10.1 Market segments
- 10.2 Comparison by Product Type
- 10.3 Microfluidic-based devices - Market size and forecast 2025-2030
- 10.4 Microfluidic components - Market size and forecast 2025-2030
- 10.5 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 APAC - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Australia - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 South America - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Argentina - Market size and forecast 2025-2030
- 12.6.3 Chile - Market size and forecast 2025-2030
- 12.7 Middle East and Africa - Market size and forecast 2025-2030
- 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
- 12.7.2 UAE - Market size and forecast 2025-2030
- 12.7.3 South Africa - Market size and forecast 2025-2030
- 12.7.4 Israel - Market size and forecast 2025-2030
- 12.7.5 Turkey - Market size and forecast 2025-2030
- 12.8 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Decentralized point of care diagnostics demand
- Expansion of precision medicine and genomics
- Adoption of organ on chip models
- 13.2 Market challenges
- Manufacturing complexity and integration constraints
- Regulatory approval and compliance delays
- Material compatibility and reagent stability
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Rise of continuous wearable microfluidic biosensors
- Adoption of microfluidic lipid nanoparticle synthesis
- Implementation of microfluidic cell isolation workflows
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 10X Genomics Inc.
- 10X Genomics Inc. - Overview
- 10X Genomics Inc. - Product / Service
- 10X Genomics Inc. - Key offerings
- SWOT
- 15.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.6 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.8 Elvesys SAS
- Elvesys SAS - Overview
- Elvesys SAS - Product / Service
- Elvesys SAS - Key offerings
- SWOT
- 15.9 Fluigent SA
- Fluigent SA - Overview
- Fluigent SA - Product / Service
- Fluigent SA - Key offerings
- SWOT
- 15.10 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 15.11 Microfluidic Chipshop GmbH
- Microfluidic Chipshop GmbH - Overview
- Microfluidic Chipshop GmbH - Product / Service
- Microfluidic Chipshop GmbH - Key offerings
- SWOT
- 15.12 MIMETAS BV
- MIMETAS BV - Overview
- MIMETAS BV - Product / Service
- MIMETAS BV - Key offerings
- SWOT
- 15.13 Parker Hannifin Corp.
- Parker Hannifin Corp. - Overview
- Parker Hannifin Corp. - Business segments
- Parker Hannifin Corp. - Key news
- Parker Hannifin Corp. - Key offerings
- Parker Hannifin Corp. - Segment focus
- SWOT
- 15.14 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.15 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 15.16 SMC Corp.
- SMC Corp. - Overview
- SMC Corp. - Product / Service
- SMC Corp. - Key offerings
- SWOT
- 15.17 Standard BioTools Inc.
- Standard BioTools Inc. - Overview
- Standard BioTools Inc. - Product / Service
- Standard BioTools Inc. - Key offerings
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
